Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
dorsaVi Limited ( (AU:DVL) ) has shared an update.
dorsaVi Limited has appointed MVAB Audit Pty Ltd as its new auditor, following the resignation of MVAB Assurance, with the change driven by the incorporation of the existing audit practice. The company emphasized that there will be no change to the audit engagement partner, team, scope, or approach, characterizing the move as an administrative and structural adjustment rather than a response to any audit, governance, or independence concerns.
ASIC has consented to the auditor change, and shareholders will be asked to confirm MVAB Audit’s appointment at dorsaVi’s 2026 annual general meeting. The seamless transition is intended to maintain continuity in the company’s audit processes while aligning its corporate structure with the reorganized audit practice, signaling stability for investors and other stakeholders.
The most recent analyst rating on (AU:DVL) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
dorsaVi Limited is an ASX-listed technology company focused on ultra-edge intelligence, enabling real-time AI-driven decisions to be made locally at the point of sensing without relying on cloud connectivity. Its wearable sensor technology captures and analyzes human movement and posture in real-world settings for up to 24 hours, supporting applications across clinical care, elite sports performance, and occupational health and safety.
dorsaVi is also investing in neuromorphic computing and RRAM memory technologies to build the hardware foundations of ultra-edge processing, targeting industrial, clinical, and autonomous systems markets. The company’s solutions are used by major corporations to reduce workplace injury risk and compensation claims, and its ViMove+ clinical platform provides objective assessment, remote monitoring, and biofeedback for physiotherapy, hospital-in-the-home, and elite sports use cases.
Average Trading Volume: 994,416
Technical Sentiment Signal: Sell
Current Market Cap: A$32.67M
See more data about DVL stock on TipRanks’ Stock Analysis page.